Literature DB >> 3508748

The influence on survival of season of onset of childhood acute lymphoblastic leukemia (ALL).

P Cohen1.   

Abstract

Rhythmicity has been found to be an important characteristic of leukocytes. We tested, therefore, whether rhythmicity could be found to be reflected in one or more of the developmental stages of childhood acute lymphoblastic leukemia. The patient material comprised 205 children 96 girls and 106 boys) whose disease was diagnosed in Israel during the years 1976-1981. Their mean age was 5.9 years +/- 3.94. No seasonal onset of disease was found, either in the whole group or in subgroups divided by sex or lymphocyte surface markers. Survival analyses however, revealed that the season of diagnosis influenced survival. Excluded from the study were 9 cases (4.4%) due to lack of some items. The follow-up period was between 1 and 72 months (median 26 months). It appeared that the life table curves were running in their temporal order, each following curve representing a consecutive 3-month period. The difference between the curves was statistically significant (p = 0.025/0.009). The survival percentages at the end of the follow-up increased steadily, from a trough during November-January (56.5%) to a peak in August-October (80.0%). Analysis by sex and white blood cell (WBC) count showed that the difference between the life table curves was primarily due to girls presenting less than 50,000 cells per cumm (n = 73, p = 0.005/0.0028). The survival percentages in the same order as mentioned earlier were: 47.1%, 68.4%, 89.5% and 94.4%. The steady rise in the different female time series suggests a circannual pattern.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3508748     DOI: 10.3109/07420528709078536

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  1 in total

1.  The relationship between seasonal variation in the diagnosis of acute lymphoblastic leukemia and its prognosis in children.

Authors:  Mehmet Mutlu; Erol Erduran
Journal:  Turk J Haematol       Date:  2012-06-15       Impact factor: 1.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.